InsidersTradesSigma
Follow the 奥锐特 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 奥锐特 has logged 12 public disclosures. Market capitalisation: €7.9bn. The latest transaction was filed on 10 March 2026 (Sale). Among the most active insiders: 邱培静. The full history is free.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€6m
12 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,230 of 29,063 companies
64.1
score / 100
Value52
Quality76
FCF yld0.9%
Earn yld5.7%
EV/EBITDA13.1x
ROE15%
Gross mgn60%
Net mgn26%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 March 2026
Declarations12 total
12 of 12 declarations
About 奥锐特
奥锐特 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative pharmaceutical products.